“anti-TNF drugs”的搜索结果，显示 601-610 项，共有 6886 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Chemotherapy drugs, such as methotrexate, vinblastine, doxorubicin, cisplatin, and gemcitabine work in different ways to stop the growth of tumor cells ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Ascorbic acid may make cancer cells more sensitive to chemotherapy. Drugs used in chemotherapy, work in different ways to stop the growth of cancer cells, ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Drugs used in chemotherapy regimens such as UH-3 (vincristine, doxorubicin, cyclophosphamide, carboplatin, etoposide, and irinotecan) and ICE/Cyclo/Topo ...

4. 外科 - 临床试验- 妙佑医疗国际

   ... treatment with SONALA-001 in combination with MRgFUS in subjects with progressive or rGBM. Extracellular Impact Of Ultrasound-induced Blood-brain Barrier ...

5. 血液科- 临床试验- 妙佑医疗国际

   The first part of the study includes the first two phases of therapy: Induction and Consolidation. This part will collect information on the leukemia, as well ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Although survivorship recommendations have been developed in areas such as lymphoma and stem cell transplant, the long-term effects of CAR-T therapy are unknown ...

7. 血液科- 临床试验- 妙佑医疗国际

   Ascorbic acid may make cancer cells more sensitive to chemotherapy. Drugs used in chemotherapy, work in different ways to stop the growth of cancer cells, ...

8. 脑肿瘤项目- 临床试验- 妙佑医疗国际

   Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of therapy. In addition to ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that has ...

10. 血液科- 临床试验- 妙佑医疗国际

    Drugs used in chemotherapy, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by ...